Communiqués IRRC Corporation

Actions

Marché Fermé - Japan Exchange Autres places de cotation 08:30:00 17/07/2026			Varia. 5j.	Varia. 1 janv.
672,00 ^JPY	-3,03 %		-3,86 %	-22,76 %

05/02/25	Dai-ichi Life va acquérir une participation de 6,9 % dans l'IRRC	MT
05/02/25	Dai-Ichi Life Holdings Inc - Acquisition d'une participation de 6,91 % dans IRRC Corp.	RE

05/12/23	Henlius Biotech, Inc. - Results from Four Phase 1/2 Clinical Trials of Henlius Innovative Products Released at 2023 ESMO Asia	AQ
31/03/23	CStone Announces Publication of GEMSTONE-201 Study Results for Sugemalimab Monotherapy in the Treatment of Relapsed, Refractory Extranodal NK/T-Cell Lymphoma in Journal of Clinical Oncology	AQ
06/06/22	CStone presents clinical results of sugemalimab in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma via an oral abstract session at ASCO 2022	AQ
30/07/21	IRRC : Pennsylvania Takes Next Step Toward Cap-and-Trade Amid Resistance	AQ
14/07/21	Worth Another Look: Regional Greenhouse Gas Initiative (RGGI)	AQ
25/02/20	IRRC : New Overtime Pay Regulation In Pennsylvania May Create Obligations For Employers Beyond Federal Requirements	AQ